Timothy F Feltes

Summary

Affiliation: The Ohio State University
Country: USA

Publications

  1. ncbi Palivizumab prophylaxis reduces hospitalization due to respiratory syncytial virus in young children with hemodynamically significant congenital heart disease
    Timothy F Feltes
    Ohio State University and The Children s Hospital, 700 Children s Drive, ED622, Columbus, OH 43205, USA
    J Pediatr 143:532-40. 2003
  2. ncbi Palivizumab and the prevention of respiratory syncytial virus illness in pediatric patients with congenital heart disease
    Timothy F Feltes
    The Ohio State University, Columbus Children s Hospital, 700 Children s Drive, ED 617, Columbus, Ohio 43205, USA
    Expert Opin Biol Ther 7:1471-80. 2007
  3. ncbi The current state of infection with respiratory syncytial virus in the setting of congenital cardiac malformations
    Timothy F Feltes
    Division of Pediatric Cardiology, Columbus Children's Hospital, Ohio State University, Columbus, Ohio 43205, USA
    Cardiol Young 16:136-43. 2006
  4. ncbi Increased calcium supplementation is associated with morbidity and mortality in the infant postoperative cardiac patient
    Peter C Dyke
    Department of Pediatrics, The Ohio State Unviersity, and Columbus Children s Hospital, The Heart Center, Columbus, OH 43205 2696, USA
    Pediatr Crit Care Med 8:254-7. 2007
  5. ncbi Initial counseling prior to palliation for hypoplastic left heart syndrome
    Andrew R Yates
    Nationwide Children s Hospital and Research Institute, Columbus, Ohio 43205, USA
    Congenit Heart Dis 6:347-58. 2011
  6. ncbi A randomized controlled trial of motavizumab versus palivizumab for the prophylaxis of serious respiratory syncytial virus disease in children with hemodynamically significant congenital heart disease
    Timothy F Feltes
    Department of Pediatrics, The Ohio State University and Nationwide Children s Hospital, Columbus, Ohio 43205, USA
    Pediatr Res 70:186-91. 2011
  7. ncbi Quality outcomes of ACHD patients undergoing cardiovascular procedures and hospital admissions in a free-standing children's hospital
    Stephen R Crumb
    Nationwide Children s Hospital, Columbus, OH 43205, USA
    Int J Cardiol 146:326-9. 2011
  8. ncbi Hepatic necrosis following repair of totally anomalous pulmonary venous connection
    Abigail Fischer
    Division of Pediatric Cardiology, The Heart Center, Columbus Children s Hospital and The Ohio State University, Columbus, Ohio 43220, USA
    Cardiol Young 17:435-7. 2007
  9. ncbi Echocardiographic evaluation of the single right ventricle in congenital heart disease: results of new techniques
    Clifford L Cua
    Heart Center, Nationwide Children s Hospital, Columbus, OH 43205, USA
    Circ J 76:22-31. 2012
  10. ncbi Hyperglycemia is a marker for poor outcome in the postoperative pediatric cardiac patient
    Andrew R Yates
    Department of Pediatrics, The Ohio State University College of Medicine, Columbus, OH 43205 2696, USA
    Pediatr Crit Care Med 7:351-5. 2006

Collaborators

Detail Information

Publications17

  1. ncbi Palivizumab prophylaxis reduces hospitalization due to respiratory syncytial virus in young children with hemodynamically significant congenital heart disease
    Timothy F Feltes
    Ohio State University and The Children s Hospital, 700 Children s Drive, ED622, Columbus, OH 43205, USA
    J Pediatr 143:532-40. 2003
    ..To evaluate the safety, tolerance, and efficacy of palivizumab in children with hemodynamically significant congenital heart disease (CHD)...
  2. ncbi Palivizumab and the prevention of respiratory syncytial virus illness in pediatric patients with congenital heart disease
    Timothy F Feltes
    The Ohio State University, Columbus Children s Hospital, 700 Children s Drive, ED 617, Columbus, Ohio 43205, USA
    Expert Opin Biol Ther 7:1471-80. 2007
    ..Palivizumab is one of the first monoclonal antibodies to significantly impact a pediatric disease...
  3. ncbi The current state of infection with respiratory syncytial virus in the setting of congenital cardiac malformations
    Timothy F Feltes
    Division of Pediatric Cardiology, Columbus Children's Hospital, Ohio State University, Columbus, Ohio 43205, USA
    Cardiol Young 16:136-43. 2006
  4. ncbi Increased calcium supplementation is associated with morbidity and mortality in the infant postoperative cardiac patient
    Peter C Dyke
    Department of Pediatrics, The Ohio State Unviersity, and Columbus Children s Hospital, The Heart Center, Columbus, OH 43205 2696, USA
    Pediatr Crit Care Med 8:254-7. 2007
    ..The purpose of this study was to assess the association of calcium replacement therapy with morbidity and mortality in infants after cardiac surgery involving cardiopulmonary bypass...
  5. ncbi Initial counseling prior to palliation for hypoplastic left heart syndrome
    Andrew R Yates
    Nationwide Children s Hospital and Research Institute, Columbus, Ohio 43205, USA
    Congenit Heart Dis 6:347-58. 2011
    ..We sought to examine what procedure, if any, is recommended for HLHS management in regard to physician preference, anatomical variations, and concomitant medical issues...
  6. ncbi A randomized controlled trial of motavizumab versus palivizumab for the prophylaxis of serious respiratory syncytial virus disease in children with hemodynamically significant congenital heart disease
    Timothy F Feltes
    Department of Pediatrics, The Ohio State University and Nationwide Children s Hospital, Columbus, Ohio 43205, USA
    Pediatr Res 70:186-91. 2011
    ..Safety and efficacy were consistent with another study comparing motavizumab with palivizumab in premature infants without CHD...
  7. ncbi Quality outcomes of ACHD patients undergoing cardiovascular procedures and hospital admissions in a free-standing children's hospital
    Stephen R Crumb
    Nationwide Children s Hospital, Columbus, OH 43205, USA
    Int J Cardiol 146:326-9. 2011
    ..Describe quality outcomes of adults with congenital heart disease (ACHD) undergoing cardiovascular procedures and admissions in a free-standing children's hospital with a multi-disciplinary ACHD program and compared with pediatric outcomes...
  8. ncbi Hepatic necrosis following repair of totally anomalous pulmonary venous connection
    Abigail Fischer
    Division of Pediatric Cardiology, The Heart Center, Columbus Children s Hospital and The Ohio State University, Columbus, Ohio 43220, USA
    Cardiol Young 17:435-7. 2007
    ..We describe associated anomalies of the portal venous system...
  9. ncbi Echocardiographic evaluation of the single right ventricle in congenital heart disease: results of new techniques
    Clifford L Cua
    Heart Center, Nationwide Children s Hospital, Columbus, OH 43205, USA
    Circ J 76:22-31. 2012
    ..As this complex population continues to increase in number, accurate and precise evaluation of RV function will be a major issue in determining clinical care...
  10. ncbi Hyperglycemia is a marker for poor outcome in the postoperative pediatric cardiac patient
    Andrew R Yates
    Department of Pediatrics, The Ohio State University College of Medicine, Columbus, OH 43205 2696, USA
    Pediatr Crit Care Med 7:351-5. 2006
    ..Minimal data exist in postoperative pediatric cardiac patients. The goal of this study was to determine whether hyperglycemia in the postoperative period was associated with increased morbidity or mortality...
  11. ncbi Acute and long-term effects of infection by the respiratory syncytial virus in children with congenital cardiac malformations
    Timothy F Feltes
    Section of Pediatric Cardiology, Ohio State University, Columbus, OH 43205, USA
    Cardiol Young 15:266-73. 2005
    ..Indeed, an increasing body of evidence supports this hypothesis, indicating a clinical rationale for prophylaxis against the virus in infancy, in order to reduce the chance of developing reactive airways disease and asthma in later life...
  12. ncbi The European Forum for Clinical Management: prophylaxis against the respiratory syncytial virus in infants and young children with congenital cardiac disease
    Robert M R Tulloh
    Department of Paediatric Cardiology, Bristol Royal Hospital for Children, Bristol, United Kingdom
    Cardiol Young 15:274-8. 2005
    ..The recommendations resulting from the discussions are presented in this paper, as a step towards reaching consensus...
  13. ncbi Infection by the respiratory syncytial virus in infants and young children at high risk
    Damien Bonnet
    Paediatric Cardiology, Hopital Necker Enfants Malades, Paris, France
    Cardiol Young 15:256-65. 2005
    ..National and international guidelines, therefore, now recommend routine prophylaxis in the first year of life in children with haemodynamically significant congenital cardiac disease...
  14. ncbi Improved early results with the Fontan operation in adults with functional single ventricle
    Antonio R Mott
    Department of Pediatrics, Baylor College of Medicine, Texas Children s Hospital, Houston 77030, USA
    Ann Thorac Surg 77:1334-40. 2004
    ..This study describes the clinical presentation and early operative results of adults who have undergone Fontan modifications...
  15. ncbi Mediastinitis after pediatric cardiac surgery: a 15-year experience at a single institution
    Tia A Tortoriello
    The Lillie Frank Abercrombie Section of Pediatric Cardiology, The Heart Center, Texas Children's Hospital, Baylor College of Medicine, Houston, Texas, USA
    Ann Thorac Surg 76:1655-60. 2003
    ..Subsequent redo-sternotomy has not been problematic...
  16. ncbi Association of nitric oxide dose and methemoglobin levels in patients with congenital heart disease and pulmonary hypertension
    Elise M Riddle
    Center for Pediatric Cardiology, Las Vegas, Nevada 89106, USA
    Am J Cardiol 90:442-4. 2002
  17. ncbi Internet use in families with children requiring cardiac surgery for congenital heart disease
    Catherine M Ikemba
    Department of Pediatrics, Texas Children's Hospital, Baylor College of Medicine, Houston, Texas 77030, USA
    Pediatrics 109:419-22. 2002
    ..Our vigilance in providing accurate Internet references, as well as in identifying inaccurate Internet information available to our patients and their parents, is of paramount importance...